Back to Markets
ASAscendis Pharma A/S

Ascendis Pharma A/S

ASNDNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$224.11

-13.360000 (-5.63%)

As of 05/29/26 EDT · USD

Compare
Low: $160.86Current: $224.11High: $250.74

Key Statistics

Open

$236.00

Day High

$236.00

Day Low

$218.08

Prev. Close

$237.47

VolumeShares traded today.

1.26M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$13.92B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

25.55

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$250.74

52W LowLowest price over the past 52 weeks.

$160.86

50D MAAverage closing price over the last 50 trading days.

200D MAAverage closing price over the last 200 trading days.

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

-9.5%

1M

+1.7%

6M

YTD

-8.7%

1Y

-8.7%

About

Growth hormone therapy refers to the use of growth hormone (GH) as a prescription medication—it is one form of hormone therapy. Growth hormone is a peptide hormone secreted by the pituitary gland that stimulates growth and cell reproduction. In the past, growth hormone was extracted from human pituitary glands. Growth hormone is now produced by recombinant DNA technology and is prescribed for a variety of reasons. GH therapy has been a focus of social and ethical controversies for 50 years.

ascendispharma.dk/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade ASND

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.